As listed in Table 7, significantly lower GCS scores, substantially higher hematoma volumes, blood glucose levels, and serum neuritin levels, and markedly higher proportions of intraventricular hemorrhage and diabetes mellitus were confirmed in patients with END than in those without (all p < 0.05). Here, NRN1 is linked to hematoma.